Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

JMC Partners LLP

JMC Partners is an established communications consultancy, with a particular expertise in healthcare. We have an excellent record of informing and influencing public policy on behalf of our clients. In a constantly evolving public policy environment, we work together with our clients to help them navigate the political process and convey their message to the people that count in Westminster and beyond. Our dedicated team provides a truly personalised service based on a genuine understanding of our clients’ goals and aspirations. We pride ourselves on the relationships we build and the results we achieve.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Health policy and government affairs, Market access, Market research

Company Details

JMC Partners LLP
Hudson House, 8 Tavistock Street, London, WC2E 7PP, United Kingdom
020 3178 7569
Contact JMC Partners LLP
Website

 Latest Content from PMHub 

HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW

Press Releases | July 14, 2022 | Wilmington Healthcare

Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to...

Accelerating patient recruitment post-COVID-19

White Papers and Resources | July 12, 2022 | Innovative Trials

COVID-19 has hugely affected clinical trials and patient recruitment, with the entire industry on hold for some time causing backlogs and delays most of the studies.

Genesis Research Acquires Market Access Transformation

Press Releases | July 11, 2022 | Genesis Research Group

Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has entered into a definitive agreement to acquire Market Access Transformation (“MAT”),...

Bedrock’s Accelerated Virtual Consensus Programme for Merck wins at Communiqué Awards

Press Releases | July 11, 2022 | Bedrock Healthcare Communications

The award recognises outstanding achievement in flexing thinking and processes to ensure success.

ISPOR 2022: a retrospective

Videos and Podcasts | July 11, 2022 | Genesis Research Group

Genesis Research – an introduction

Videos and Podcasts | July 11, 2022 | Genesis Research Group

Ensuring fit-for-purpose real-world data to generate real-world evidence with Susan Oliveria

Videos and Podcasts | July 11, 2022 | Genesis Research Group

Genesis Research at the World EPA Congress 2022

Videos and Podcasts | July 11, 2022 | Genesis Research Group

Traversing the Medtech Regulatory Landscape in the Interest of Patients

Videos and Podcasts | July 7, 2022 | Impetus Digital

Dr. Bassil Akra, CEO of AKRA TEAM GmbH, takes a deep dive into the new approval process for medical devices in the EU and shares how his company is supporting...

Diabetes management – should there be a ‘one-size fit all’ approach?

White Papers and Resources | July 7, 2022 | IGNIFI

For Diabetes Awareness Week 2022, we discussed diabetes as a chronic condition, and the increasing importance of home-based disease management.